We last reviewed the charts of Perrigo Corp. (PRGO) on April 9, 2020. We wrote that "After dealing with a drug recall fiasco two years ago I cannot wait for drugs and supplements to be made in the U.S. again. I guess I have some skin in the game when I look at PRGO. Traders could approach the long side of PRGO at current levels, risking a close below $41. Our initial upside price target is $56."
More from Stocks
These recently downgraded names are displaying both quantitative and technical deterioration.
Luck impacts our trading much more than we realize. Acknowledging that fact can help improve results.
Risk-averse investors can reduce portfolio volatility by buying quality dividend growth stocks.
While indices are hitting all-time highs, 60% of stocks are struggling or in outright bear markets.